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ABSTRACT
Background: Being overweight is the main risk factor for many chronic disorders, especially 
cardiovascular diseases. Hypertension is the first reaction of the heart to overburdens imposed 
by obesity or overweightness. In this study, we evaluated the correlation between body mass 
index (BMI) and echocardiographic findings in overweight patients compared to normal-weight 
patients. Methods: This historical cohort study was conducted on 60 patients divided into two 
groups of 30 based on their measured weight: group 1 had a BMI of 20-25 kg/m2 and was 
the control; group 2 had a BMI of >25-30 kg/m2. Demographic and clinical data, as well as 
echocardiographic results, were recorded for all patients. Results: The mean age of patients in 
the control group (41.06 ± 12.82 years) and the overweight group (46.84 ± 12.61 years) was not 
significantly different (P = 0.067). Systolic blood pressure (P = 0.003) and pulse rate (P = 0.028) 
were significantly higher in the overweight group. Ejection fraction (P = 0.036); end-systolic 
(P < 0.001) and end-diastolic (P < 0.001) left ventricular dimensions; and left ventricular mass 
index (P = 0.005) were significantly higher in the control group. Conclusion: Overweightness 
due to anatomical remodeling can cause diastolic heart failure in the left ventricle. According to 
the relatively poor prognosis of treatment features in patients with probable risk factors for heart 
failure, such as diabetes, hypertension, and ischemic heart disease, we recommend considering 
overweightness as a strong prognostic factor for heart failure.
INTRODUCTION
Overweightness is a common condition and is a primary risk 
factor for many chronic disorders. The principal cause of 
death for people who are overweight and obese is cardio-
vascular disease; stroke and renal failure are also common in 
obese people (1-3).
When someone is overweight or obese, their ventricular 
wall can be overburdened with pressure, which can lead to 
hypertrophy as a compensatory mechanism. Hypertrophy, re-
gardless of the cause, can lead to cardiac muscle stiffness and 
elevated metabolic requirements, resulting in cardiac output 
being limited in times of physical stress (4,5). The first heart 
reaction to obesity- or overweightness-related overburdening 
is hypertension, which is characterized by increased ventricu-
lar wall thickness. This can result in dysfunction of this cavity 
and symptoms of heart failure. Left ventricular hypertrophy 
(LVH) can be diagnosed most sensitively and accurately with 
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chest X-ray (6). Diagnosis by echocardiography is based on 
direct observation of the heart and measurement of the pa-
rameters necessary for calculating the left ventricular mass 
and the index of left ventricular function (7).
LVH is an important risk factor for cardiovascular diseas-
es. Given the increasing prevalence of cardiovascular diseas-
es, current research in this area has been shifting away from 
treatment to prevention, and studies on preventive cardiolo-
gy are much more significant than other types of studies. Ac-
cordingly, in our study we evaluated the correlation between 
body mass index (BMI) and echocardiographic findings in 
overweight patients compared to normal-weight patients.
METHODS
In this retrospective, historical cohort study, patients were 
divided into two groups based on the independent variable of 
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BMI: group 1 had a BMI of 20-25 kg/m2 and was the control; 
group 2 had a BMI of >25-30 kg/m2. Statistical consultation 
determined that the sample size should be at least 60 patients 
in two groups of 30 (normal weight and overweight).
Exclusion criteria were age over 60 years, BMI greater 
than 30 or less than 20 (5), diabetes (6), intermittent smok-
ing and alcohol use (7), periodic or regular physical isometric 
exercise (8), history of antihypertensive drugs (9), congestive 
heart failure, kidney failure, pregnancy, abnormal echocar-
diogram at rest, positive exercise test, and heart valve lesions.
All echocardiographs were performed by a skilled tech-
nician using General Electric Vivid-3 echocardiography. 
Definitions of left ventricular echocardiography parame-
ters, including ejection fraction, fractional shortening, and 
left ventricular relative wall thickness (10), were taken from 
the guidelines of the American Society of Echocardiogra-
phy (11).
RESULTS
Demographic and hemodynamic variables in the two groups 
are presented in Table 1. We observed that heart rate and sys-
tolic blood pressure were significantly higher in overweight 
patients. The height of the patients was not significantly dif-
ferent between the two groups; weight was the only reason 
for differences in BMI.
Comparison of echocardiographic findings in the two 
groups showed that interventricular septum and posterior 
wall of the left ventricle in both end-systolic and end-diastol-
ic dimensions were not significantly different between the 
two groups; however, ejection fraction, left ventricular thick-
ness, and left ventricular mass index were significantly lower 
in the overweight group than in the control group (Table 2).
As shown in Table 3, no significant differences in Dop-
pler echocardiographic findings were observed between the 
two groups.
DISCUSSION
Being overweight is the main risk factor for many chronic 
disorders, especially cardiovascular diseases (12). Obesi-
ty-related cardiovascular diseases often result in heart fail-
ure and become more common with increasing age (13). 
However, heart failure is mainly a diastolic disorder and 
has a strong association with anatomical remodeling of the 
left ventricle and its valves (12). Apart from age, history of 
diabetes mellitus, female sex, history of hypertension, and 
obesity are among the most common risk factors for left ven-
tricular diastolic dysfunction (14). Although recent studies 
have identified obesity as the primary risk factor for left ven-
tricular remodeling, preventive cardiology has an import-
ant role to play in reducing the risk of heart disease. From 
this perspective, overweightness, not obesity, is considered 
a warning for patients at risk (15,16). In this study, we ex-
amined overweight people in comparison to normal-weight 
people from this perspective.
Table 1. Evaluation of the demographic factors affecting the left ventricular parameters in the two groups
Demographic variables Normal-weight group 
(BMI = 20-25 kg/m2)
Overweight group 
(BMI = >25-30 kg/m2)
P value
Age (years) 41.06±12.82 46.84±12.61 0.067
Heart rate (bpm) 79.34±9.25 84.13±7.93 0.028
Systolic blood pressure (mmHg) 125.66±16.75 137.10±14.31 0.003
Diastolic blood pressure (mmHg) 83.00±14.41 87.36±9.77 0.142
Height (cm) 162.96±8.51 161.18±11.33 0.476
Weight (kg) 61.60±7.23 73.76±11.1 <0.001
BMI (kg/m2) 23.14±1.43 28.28±2.14 <0.001
BMI: Body mass index
Table 2. Evaluation of the left ventricular echocardiographic findings in the two groups
Demographic variables Stages Normal-weight group 
(BMI = 20-25 kg/m2)
Overweight group 
(BMI = >25-30 kg/m2)
P value
Interventricular septum thickness (mm) End-diastolic 16.01±3.23 15.86±3.86 0.865
End-systolic 10.79±2.94 10.37±2.38 0.520
Posterior wall thickness (mm) End-diastolic 15.58±2.56 15.89±2.84 0.635
End-systolic 11.43±2.1 11.69±3.03 0.690
Ejection fraction 61.50±5.43 57.63±8.6 0.036
Fractional shortening 32.17±9.75 29.68±9.13 0.282
End-diastolic 38.84±6.08 32.13±5.78 <0.001
End-systolic 32.47±6.66 26.3±5.31 <0.001
Mass index (g/m2) 53.25±8.64 49.45±8.88 0.005
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We found that end-systolic and end-diastolic left ven-
tricular dimensions were significantly lower in overweight 
patients than in normal-weight patients. Redfield et al. (17) 
found significant effects of overweightness on the left ven-
tricular size. However, in their study, only patients with a 
BMI greater than 30 kg/m2 were selected, and overweight 
and obese patients were not included.
Decreased left ventricular size, except for the reduction of 
end-systolic and end-diastolic dimensions, is also measured 
using a more precise indicator called the left ventricular mass 
index. In our study, the left ventricular mass index in over-
weight patients was lower than the left ventricular mass index 
in normal-weight patients. Considering the significant differ-
ence in systolic blood pressure between the two groups and 
regarding the interval between the incidence of blood pres-
sure in patients, the difference in left ventricular mass index 
between the two groups can be interpreted well. In a similar 
study, Yu et al. (18) reported that the left ventricular mass 
index and the ejection fraction in obese patients were lower 
than in normal-weight patients, which is completely in line 
with the results of our study. This finding suggests the need 
for preventive cardiologic strategies in overweight patients.
CONCLUSION
A significant correlation exists between overweightness and 
left ventricular anatomical remodeling, which can acceler-
ate the onset of left ventricular diastolic dysfunction. Con-
sidering the relatively poor prognosis of patients with left 
ventricular diastolic dysfunction, and that these patients are 
often treated only symptomatically, we recommend that, to 
prevent heart failure, further complications, and subsequent 
disabilities, overweightness factors— such as diabetes, high 
blood pressure, and ischemic heart disease—be regarded se-
riously in patients with possible risk factors for cardiovas-
cular diseases. Therefore, not only patients at risk, but also 
middle-aged populations, should undergo necessary diet and 
lifestyle modifications and get regular physical isometric ex-
ercises to lose weight and prevent possible complications of 
heart failure. Additional comprehensive studies with larger 
sample sizes and that consider other potential risk factors are 
needed to verify or modify the findings of this and similar 
studies.
Study Limitations
Since the exclusion criteria of our study included a wide 
range of cardiac and non-cardiac diseases, the sampling time 
was longer than expected. Moreover, echocardiography re-
quired a longer duration than is normal for other patients. In 
addition to requiring more time, this raised the cost of echo-
cardiography for each patient beyond the cost of a typical 
echocardiography.
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